Growth Metrics

Ultragenyx Pharmaceutical (RARE) Shareholder's Equity (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -195.00%
Dec 31, 2025 -973.46%
Sep 30, 2025 -93.95%
Jun 30, 2025 5.06%
Mar 31, 2025 -43.53%
Dec 31, 2024 -26.48%
Sep 30, 2024 -19.79%
Jun 30, 2024 208.29%
Mar 31, 2024 -48.99%
Dec 31, 2023 767.12%
Sep 30, 2023 -75.42%
Jun 30, 2023 -41.48%
Mar 31, 2023 -37.36%
Dec 31, 2022 -24.92%
Sep 30, 2022 -30.86%
Jun 30, 2022 -14.86%
Mar 31, 2022 -13.67%
Dec 31, 2021 -1.19%
Sep 30, 2021 -3.96%
Jun 30, 2021 -7.81%
Mar 31, 2021 -8.64%
Dec 31, 2020 73.28%
Sep 30, 2020 -4.23%
Jun 30, 2020 14.19%
Mar 31, 2020 -6.82%
Dec 31, 2019 -10.11%
Sep 30, 2019 -11.29%
Jun 30, 2019 -7.55%
Mar 31, 2019 45.63%
Dec 31, 2018 -8.10%
Sep 30, 2018 -5.88%
Jun 30, 2018 -2.72%
Mar 31, 2018 88.72%
Dec 31, 2017 4.90%
Sep 30, 2017 -14.88%
Jun 30, 2017 -12.08%
Mar 31, 2017 3.06%
Dec 31, 2016 3.97%
Sep 30, 2016 2.70%
Jun 30, 2016 482,394.57%
Mar 31, 2016 -99.98%
Dec 31, 2015 -7.92%
Sep 30, 2015 80.65%
Jun 30, 2015 -6.40%
Mar 31, 2015 84.44%
Dec 31, 2014 -7.21%
Sep 30, 2014 30.21%
Jun 30, 2014 -7.62%
Mar 31, 2014 321.48%